Dianthus Therapeutics, Inc. Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

DNTH

Peringkat dalam Saham #3912
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in... Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Harga Saham
$75.21
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$4.21B
Perubahan (1 hari)
4.33%
Perubahan (1 tahun)
108.93%
Negara
US
Perdagangan Dianthus Therapeutics, Inc. (DNTH)

Kategori

Healthcare
Riwayat pemecahan saham untuk Dianthus Therapeutics, Inc. (DNTH)
Saham Dianthus Therapeutics, Inc. (simbol: DNTH) telah mengalami total 1 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Sep 12, 2023.
Satu lembar saham DNTH yang dibeli sebelum Sep 12, 2023 sekarang setara dengan 0.0625 lembar saham DNTH.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2023-09-12 1:16 x0.0625 x0.0625
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL